Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Epilepsy Market: By Product Type Market Trends, Size, and Future Outlook
- By Product Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Product Type Definitions, Technology Landscape
- By Product Type Market Drivers
- Product Launches
- Technology Launches
- By Product Type Market Restraints
- Chapter 4. Epilepsy Market: By Seizure Type Market Trends, Size, and Future Outlook
- By Seizure Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Seizure Type Definitions, Technology Landscape
- By Seizure Type Market Drivers
- Product Launches
- Technology Launches
- By Seizure Type Market Restraints
- Chapter 5. Epilepsy Market: By End-User Market Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
- Chapter 6. Epilepsy Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- North America
- Epilepsy Market: Competitive Landscape
- UCB S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sunovion Pharmaceuticals Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eisai Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Shire plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bial - Portela & CA, S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Lundbeck A/S
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Supernus Pharmaceuticals, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Zogenix, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- SK Biopharmaceuticals Co., Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Neurelis, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Cavion, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Upsher-Smith Laboratories, LLC
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Xenon Pharmaceuticals Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Encoded Therapeutics, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- UCB S.A.
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Epilepsy industry is US$ 2.12 billion.
The key factors driving the growth of the Epilepsy market include growing prevalence of epilepsy, advancements in anti-seizure medications, expansion of treatment options, increasing adoption of digital health technologies, and advancements in neuroimaging and diagnostic techniques.
The key factors hampering the growth of the Epilepsy Market include high cost of advanced epilepsy treatments, side effects associated with anti-seizure medications, limited access to specialized care in certain regions, and lack of awareness and social stigma surrounding epilepsy.
The leading component segment in the Epilepsy Market is the Anti-seizure Medications segment, which accounts for a significant market share due to the continuous development of new and more effective drugs by pharmaceutical companies.
The major players operating in the Epilepsy Market include UCB S.A., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Sunovion Pharmaceuticals Inc., Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, and Shire plc.
The Epilepsy Market is expected to grow at a CAGR of 3.2% during the forecast period, reaching a market size of US$ 2.7 billion by 2031.
The key drivers of the Epilepsy Market include growing prevalence of epilepsy, increased awareness and diagnosis of the condition, advancements in anti-seizure medications, and expansion of treatment options, including surgical interventions.